Wednesday, May 05, 2021 1:11:34 PM
Source: Dow Jones News
By Kim Mackrael and Jared S. Hopkins
OTTAWA -- Canada authorized the use of the Pfizer-BioNTech Covid-19 vaccine for adolescents, moving ahead of the U.S. Food and Drug Administration and marking the first time a Covid-19 vaccine will be available for children in North America.
Health Canada said its authorization means children between the ages of 12 and 15 will be able to receive the Pfizer-BioNTech vaccine. It didn't provide a timeline for when the two-dose shot would become available to that age group.
The Covid-19 vaccine developed by Pfizer Inc. and BioNTech SE was found to be 100% effective in protecting against symptomatic disease in a study of more than 2,200 children, the companies said in late March. Researchers didn't find any safety concerns.
Canadian officials said they reviewed the study's results in making their decision. "After completing a thorough and independent scientific review of the evidence, the department determined the vaccine is safe and effective when used in this younger age group," said Dr. Supriya Sharma, senior medical adviser at Health Canada.
The FDA is considering a request for authorization of the Pfizer-BioNTech vaccine for adolescents, which could make the vaccine available to children in the coming weeks. Regulators in Europe are also reviewing a request to authorize the vaccine for children.
Pfizer said Tuesday that it plans to ask U.S. regulators to authorize the vaccine for children between 2 and 11 years old in September, should a study under way prove positive.
Children are at lower risk of Covid-19 infection than adults, according to health experts, and when they are infected they tend to experience milder symptoms. Yet some can become seriously ill and some can spread the virus.
The vaccine's expanded use is expected to boost Canada and the world's vaccination campaign seeking to immunize as many people as possible before dangerous variants able to elude shots emerge.
Canada has experienced a damaging third wave of infections in recent months after a slow start to its vaccination campaign, prompting some jurisdictions to close schools, restaurants and nonessential stores. Canada's per capita rate of reported Covid-19 cases surpassed that of the U.S. for the first time last month, but cases in Canada have leveled off in recent weeks.
"Today's expansion of our authorization represents a significant step forward in helping the Canadian government broaden its vaccination program and begin to help protect adolescents before the start of the next school year," said Fabien Paquette, head of vaccines for Pfizer's Canadian subsidiary.
Write to Kim Mackrael at kim.mackrael@wsj.com and Jared S. Hopkins at jared.hopkins@wsj.com
(END) Dow Jones Newswires
May 05, 2021 12:19 ET (16:19 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
BNTX $$$
DO always your own DD , before you invest in any stock !
My opinion is always only my opinion !
Good Luck to all !
Recent BNTX News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/18/2024 11:28:56 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/17/2024 08:14:09 PM
- BioNTech to Host AI Day as an Edition of its Innovation Series on October 1, 2024 • GlobeNewswire Inc. • 09/17/2024 10:45:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/16/2024 09:35:58 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/16/2024 08:12:01 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/13/2024 08:12:57 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/05/2024 12:53:58 PM
- BioNTech to Present Clinical Data Updates Across mRNA and Immunomodulatory Oncology Portfolio at ESMO Congress 2024 • GlobeNewswire Inc. • 09/05/2024 11:15:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/22/2024 08:31:39 PM
- Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine • Business Wire • 08/22/2024 06:15:00 PM
- Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine • GlobeNewswire Inc. • 08/22/2024 06:15:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/19/2024 12:34:28 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/16/2024 10:56:10 AM
- Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and COVID-19 in Individuals 18-64 Years of Age • Business Wire • 08/16/2024 10:45:00 AM
- Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and COVID-19 in Individuals 18-64 Years of Age • GlobeNewswire Inc. • 08/16/2024 10:45:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/05/2024 10:34:48 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/05/2024 10:32:26 AM
- BioNTech Announces Second Quarter 2024 Financial Results and Corporate Update • GlobeNewswire Inc. • 08/05/2024 09:59:00 AM
- ASML Rises 7% on Export Waiver; Intel Plans Layoffs, HSBC $3B Buyback Announced, and More • IH Market News • 07/31/2024 09:55:50 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/30/2024 01:08:26 PM
- BioNTech Announces Positive Topline Phase 2 Results for mRNA Immunotherapy Candidate BNT111 in Patients with Advanced Melanoma • GlobeNewswire Inc. • 07/30/2024 10:45:00 AM
- BioNTech to Report Second Quarter 2024 Financial Results and Corporate Update on August 5, 2024 • GlobeNewswire Inc. • 07/22/2024 10:45:00 AM
- Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union • Business Wire • 06/27/2024 02:30:00 PM
- Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union • GlobeNewswire Inc. • 06/27/2024 02:30:00 PM
- BioNTech and DualityBio Receive FDA Fast Track Designation for Antibody-Drug Conjugate Candidate BNT324/DB-1311 in Prostate Cancer • GlobeNewswire Inc. • 06/24/2024 10:45:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM